Microsoft, CSAA, Motorola Solutions and AAA-backed emergency response technology developer RapidSOS has secured $51.2m in new funding.

Boston Metal is most of the way to a $60m target for its latest round, thanks to a consortium that included returning backer The Engine.

The oncolytic virus therapy-based cancer drug developer is based on research at Salk Institute and has raised $77m in its series A round.

Q&A with Derek Idemoto, SVP of corporate development and Cisco Investments

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Porsche and Lockheed Martin-backed lidar sensor technology developer Aeva will get the funding once its reverse merger with InterPrivate Acquisition Corp closes.

SK Biopharmaceuticals will divest a 12% stake in Arvelle, which is looking to commercialise an epilepsy drug treatment, through the acquisition.

Bristol Myers Squibb participated in a series B round for the oncology drug developer that pushed its overall funding to $168m.

The oncolytic virus therapy-based cancer drug developer raised $77m in a GV-backed series A round as it prepares to file an IND application next year.

Amazon has agreed to acquire Walt Disney and Bertelsmann-backed podcast creator and publisher Wondery for about $300m.